Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period

@article{Dueas2011TreatmentemergentSD,
  title={Treatment-emergent sexual dysfunction with SSRIs and duloxetine: Effectiveness and functional outcomes over a 6-month observational period},
  author={H. Due{\~n}as and A. Brnabic and A. Lee and {\'A}. Montejo and S. Prakash and MA. Luz S. Casimiro-Querubin and M. Khaled and M. Dossenbach and J. Raskin},
  journal={International Journal of Psychiatry in Clinical Practice},
  year={2011},
  volume={15},
  pages={242 - 254}
}
Abstract Objective. To evaluate frequencies of treatment-emergent sexual dysfunction (TESD) in patients with major depressive disorder (MDD) treated with duloxetine or selective serotonin reuptake inhibitor (SSRI) monotherapy for up to 6 months in a prospective, observational study. Methods. Sexually active MDD patients without sexual dysfunction at entry were enrolled from twelve countries (N = 1,647). TESD was assessed over the study period using the Arizona sexual experience (ASEX) scale. A… Expand
32 Citations
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
  • 67
  • Highly Influenced
...
1
2
3
4
...

References

SHOWING 1-10 OF 66 REFERENCES
Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study
  • 24
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
  • 371
  • PDF
Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.
  • 133
  • Highly Influential
Sexual dysfunction before antidepressant therapy in major depression.
  • 352
...
1
2
3
4
5
...